Standout Papers

Letrozole Is More Effective Neoadjuvant Endocrine Therapy Than Tamoxifen for ErbB-1– and/or Er... 2001 2026 2009 2017 779
  1. Letrozole Is More Effective Neoadjuvant Endocrine Therapy Than Tamoxifen for ErbB-1– and/or ErbB-2–Positive, Estrogen Receptor–Positive Primary Breast Cancer: Evidence From a Phase III Randomized Trial (2001)
    Matthew J. Ellis, Andrew Coop et al. Journal of Clinical Oncology

Immediate Impact

4 by Nobel laureates 16 from Science/Nature 131 standout
Sub-graph 1 of 19

Citing Papers

Thalassaemia
2022 Standout
A role of PIEZO1 in iron metabolism in mice and humans
2021 StandoutNobel
1 intermediate paper

Works of Erhard Quebe‐Fehling being referenced

Prevalence and distribution of iron overload in patients with transfusion‐dependent anemias differs across geographic regions: results from the CORDELIA study
2014

Author Peers

Author Last Decade Papers Cites
Erhard Quebe‐Fehling 148 172 633 1126 604 41 1.9k
H.T. Mouridsen 48 133 452 1132 1048 48 2.0k
John Hohneker 36 125 179 1435 259 39 1.9k
J. Vinholes 36 67 314 2034 620 37 2.5k
Brigitte Mlineritsch 22 75 823 2020 1080 70 2.7k
Roberto Franchi 33 126 434 964 438 63 2.3k
Giorgio Massimini 124 556 867 1271 683 31 2.8k
H. Hausmaninger 16 54 436 1317 893 53 2.1k
H. Samonigg 43 233 456 1732 894 72 2.6k
V J Bardou 14 125 538 1145 812 32 2.2k
Roberta J. Secrest 290 141 512 485 198 27 2.5k

All Works

Loading papers...

Rankless by CCL
2026